CytoMed Therapeutics Statistics
Total Valuation
GDTC has a market cap or net worth of $9.94 million. The enterprise value is $8.69 million.
| Market Cap | 9.94M |
| Enterprise Value | 8.69M |
Important Dates
The last earnings date was Friday, April 24, 2026.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
GDTC has 11.83 million shares outstanding. The number of shares has increased by 0.93% in one year.
| Current Share Class | 11.83M |
| Shares Outstanding | 11.83M |
| Shares Change (YoY) | +0.93% |
| Shares Change (QoQ) | +1.86% |
| Owned by Insiders (%) | 20.82% |
| Owned by Institutions (%) | 0.24% |
| Float | 3.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14.85 |
| Forward PS | n/a |
| PB Ratio | 1.95 |
| P/TBV Ratio | 1.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.17, with a Debt / Equity ratio of 0.07.
| Current Ratio | 5.17 |
| Quick Ratio | 3.14 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -197.19 |
Financial Efficiency
Return on equity (ROE) is -50.28% and return on invested capital (ROIC) is -31.42%.
| Return on Equity (ROE) | -50.28% |
| Return on Assets (ROA) | -29.31% |
| Return on Invested Capital (ROIC) | -31.42% |
| Return on Capital Employed (ROCE) | -56.66% |
| Weighted Average Cost of Capital (WACC) | 4.33% |
| Revenue Per Employee | $15,935 |
| Profits Per Employee | -$73,683 |
| Employee Count | 42 |
| Asset Turnover | 0.10 |
| Inventory Turnover | 0.09 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.84% in the last 52 weeks. The beta is 0.02, so GDTC's price volatility has been lower than the market average.
| Beta (5Y) | 0.02 |
| 52-Week Price Change | -54.84% |
| 50-Day Moving Average | 1.03 |
| 200-Day Moving Average | 1.26 |
| Relative Strength Index (RSI) | 37.92 |
| Average Volume (20 Days) | 42,859 |
Short Selling Information
The latest short interest is 30,057, so 0.25% of the outstanding shares have been sold short.
| Short Interest | 30,057 |
| Short Previous Month | 37,906 |
| Short % of Shares Out | 0.25% |
| Short % of Float | 0.86% |
| Short Ratio (days to cover) | 2.68 |
Income Statement
In the last 12 months, GDTC had revenue of $669,280 and -$3.09 million in losses. Loss per share was -$0.27.
| Revenue | 669,280 |
| Gross Profit | 599,495 |
| Operating Income | -3.29M |
| Pretax Income | -3.11M |
| Net Income | -3.09M |
| EBITDA | -2.89M |
| EBIT | -3.21M |
| Loss Per Share | -$0.27 |
Balance Sheet
The company has $1.63 million in cash and $375,176 in debt, with a net cash position of $1.25 million or $0.11 per share.
| Cash & Cash Equivalents | 1.63M |
| Total Debt | 375,176 |
| Net Cash | 1.25M |
| Net Cash Per Share | $0.11 |
| Equity (Book Value) | 5.33M |
| Book Value Per Share | 0.43 |
| Working Capital | 2.30M |
Cash Flow
In the last 12 months, operating cash flow was -$2.88 million and capital expenditures -$497,499, giving a free cash flow of -$3.38 million.
| Operating Cash Flow | -2.88M |
| Capital Expenditures | -497,499 |
| Depreciation & Amortization | 299,215 |
| Net Borrowing | -41,759 |
| Free Cash Flow | -3.38M |
| FCF Per Share | -$0.29 |
Margins
| Gross Margin | 89.57% |
| Operating Margin | -491.75% |
| Pretax Margin | -464.23% |
| Profit Margin | n/a |
| EBITDA Margin | -1,143.01% |
| EBIT Margin | -1,266.81% |
| FCF Margin | n/a |
Dividends & Yields
GDTC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.93% |
| Shareholder Yield | -0.93% |
| Earnings Yield | -31.13% |
| FCF Yield | -34.02% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
GDTC has an Altman Z-Score of 13.12 and a Piotroski F-Score of 3.
| Altman Z-Score | 13.12 |
| Piotroski F-Score | 3 |